Methodology

All entries for: Remedy Plan Inc

October 16, 2025

Remedy Plan Inc

Orphan Drug Designation

FDA orphan drug designation: treatment of acute myeloid leukemia

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top